QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
Agreement adds new analyzer platforms and expands assay menu across key international markets SAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 688389), to exp...
ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW
Company receives top customer rating in the 2022 IMV ServiceTrak™ Awards SAN DIEGO, July 26, 2022 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced today that its subsidiary,Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and service...